Seedlabs

Independent Evidence-Grading Service for ADHD Digital Tools

A validation lab that tests ADHD apps, cognitive-training programs, and neurofeedback tools for real-world generalization and placebo/context effects, then issues evidence grades that payers, schools, and clinicians use to decide what to cover or recommend. Think 'Consumer Reports' for the crowded ADHD app market.

MedicineAttention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity DisorderPayer, school-district, and clinician-organization digital formularies for pediatric mental-health apps

Concept

An independent validation service — a "UL listing" for ADHD digital tools. Developers submit apps, cognitive-training programs, or neurofeedback systems; the service runs standardized field evaluations in pediatric ADHD populations that measure the two things current evidence says matter most:

  1. Generalization — whether gains transfer beyond the trained task to functioning at home and school (the review shows cognitive-training gains typically do not transfer).
  2. Rater, expectancy, and context effects — outcomes collected from multiple independent raters (parent, teacher, clinician) with expectancy controls, because reported effects are strongly shaped by who rates, what they expect, and where the intervention happens.

The service issues a public evidence grade (e.g., A–D) with effect sizes by rater and domain, and re-grades as data accumulate. Revenue comes from payer/school subscriptions to the graded formulary plus firewalled developer testing fees. One wedge: trustworthy evidence grades for ADHD digital tools.

Why now

The new review [0] documents that digital ADHD tools are expanding rapidly while "few are rigorously validated," that cognitive training "does not generalize beyond trained tasks," and that neurofeedback effects are "predominantly non-specific and contextual" — while intervention outcomes generally are "strongly shaped by rater, expectancy, and context." That combination (exploding tool supply, a documented validation vacuum, and known measurement confounds that inflate testimonials) is precisely the condition in which payers, school systems, and clinician organizations need an independent, methods-aware grading service before spending money or making recommendations to families.

Written by GLM · 2 Oct 2026

AI assessment

Backed by 1 paper90

A high-utility B2B validation service that solves a critical trust gap in the ADHD digital health market by quantifying generalization and placebo effects.

Evidence strength
5/5
The idea directly operationalizes the research's specific warnings about non-generalization and rater/expectancy effects into a service offering.
Market pull
4/5
Payers and school districts have high urgency to avoid wasting budgets on 'digital snake oil,' creating a strong pull for a trusted formulary.
Novelty & moat
5/5
Unlike the listed clinical tools, this is a systemic infrastructure play (a 'rating agency') rather than a diagnostic or treatment tool.
Feasibility
3/5
Running rigorous, multi-rater field trials is resource-intensive and slow, making the initial MVP harder to scale than a software-only product.
Wedge clarity
5/5
The 'evidence grade' for ADHD tools is a sharp, singular value proposition that provides immediate utility to a specific buyer.
Simplicity / focus
5/5
The product is focused on one clear function: validating ADHD tools, avoiding the trap of becoming a broad health-tech platform.

Scored by Gemma 4 · 2 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.

Persona discussion

AI personas trained on real people's expertise debate this idea as it evolves.

View the discussion →

Act on this idea

Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.

Who benefits

  • CVS Healthcompany

    Through Aetna and its payer services, CVS curates digital health formularies and must decide which ADHD apps to cover; independent grades focused on generalization and expectancy-controlled effects give it a defensible coverage standard.

  • CHADDorganization

    The national ADHD nonprofit is constantly asked by parents which apps actually work; a trusted grading service gives CHADD evidence-based recommendations to publish instead of disclaimers.

  • American Academy of Pediatricsorganization

    Pediatricians field daily questions about ADHD apps and neurofeedback programs; a graded shortlist aligned with guideline criteria fills a direct practice-support need.

  • Common Sense Mediaorganization

    Already rates children's apps and media for families; adding an ADHD evidence-efficacy rating extends its trusted seal from age-appropriateness into clinical effectiveness.

Research it builds on

  1. Advances in the management of ADHD in children and adolescents
    Philippe Robaey, Maria Rogers, Russell James Schachar · 2026 · 2 citations
    All ideas from this paper →
Leave feedback
feasibility